Comparison of the different versions of NCCN guidelines for predicting margin-negative resection of pancreatic cancer in patients undergoing upfront surgery
View abstract on PubMed
Summary
This summary is machine-generated.The 2020 National Comprehensive Cancer Network (NCCN) guidelines demonstrated superior sensitivity in predicting margin-negative (R0) resection for pancreatic cancer compared to earlier versions. Inter-reader agreement remained strong across all guideline versions evaluated.
Area Of Science
- Oncology
- Radiology
- Surgical Oncology
Background
- Pancreatic ductal adenocarcinoma (PDAC) resectability is crucial for patient outcomes.
- National Comprehensive Cancer Network (NCCN) guidelines evolve to improve surgical planning.
- Accurate prediction of margin-negative (R0) resection impacts treatment strategies.
Purpose Of The Study
- To compare NCCN guideline versions (2017, 2019, 2020) for PDAC resectability assessment.
- To evaluate the predictive accuracy of these guidelines for achieving R0 resection.
- To assess inter-reader agreement among radiologists using different NCCN guideline versions.
Main Methods
- Retrospective analysis of 283 patients undergoing upfront pancreatectomy for PDAC (2017-2019).
- Independent radiologist assessment of resectability on preoperative CT using 2017, 2019, and 2020 NCCN guidelines.
- Sensitivity, specificity, and inter-reader agreement (kappa statistics) were calculated for R0 resection prediction.
Main Results
- R0 resection was achieved in 84.5% of patients.
- The 2020 NCCN guidelines showed the highest sensitivity (76.6%) for predicting R0 resection.
- While sensitivity increased with newer guidelines, specificity was highest with the 2017 guidelines (34.1%).
- Inter-reader agreement was strong (kappa ≥ 0.83) for all guideline versions, highest with the 2020 version (kappa = 0.91).
Conclusions
- The 2020 NCCN guidelines offer improved sensitivity for predicting R0 resection in PDAC compared to 2017 and 2019 versions.
- Radiologists demonstrated strong agreement in assessing PDAC resectability across guideline versions.
- Updated NCCN guidelines may enhance preoperative planning for pancreatic cancer surgery.

